Prof. Dr. IŞIK ATAGÜNDÜZ

Yayın Ağı

Makaleler 27

1. The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia †

Candan O., Tatli I., Bakisli A., Kula B., Korkut E., Yildirim M. E., et al.

Journal of Clinical Medicine , cilt.14, sa.21, 2025 (SCI-Expanded, Scopus)

2. Characteristics of patients with diffuse large B-cell lymphoma of gastrointestinal tract: A single center experience

Ulukoylu Menguc M., YILMAZ A. F., Guren C., TEMİZ F., Arikan F., Salim S., et al.

Marmara Medical Journal , cilt.38, sa.3, ss.198-203, 2025 (ESCI)

3. Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin

ATAŞ Ü., ILTAR U., YÜCEL O. K., Salur H., BİLEK M. Ç., Ustabas T., et al.

Journal of Clinical Medicine , cilt.14, sa.20, 2025 (SCI-Expanded, Scopus)

4. Acute lymphoblastic leukemia following lenalidomide therapy in multiple myeloma patients: Two case reports and review of the literature

Candan O., DEMİRTAŞ D., TEMİZ F., YANIK A. M., YILMAZ A. F., ATAGÜNDÜZ I., et al.

Current Problems in Cancer , cilt.57, 2025 (SCI-Expanded)

5. Comparison of the Prognostic Scoring Systems in Patients with Splenic Marginal Zone Lymphoma

Kocaaslan E., ARIKAN F., yilmaz f., ATAGÜNDÜZ I., Tuğlular A. T., Toptas T.

Eurasian Journal of Medical Investigation , cilt.9, sa.2, ss.72-78, 2025 (Hakemli Dergi)

6. VEXAS syndrome — new kid in town

Mengüç M. U., Arıkan F., Bayar A., TEMİZ F., Güren C., Salim S., et al.

Acta Haematologica Polonica , cilt.56, sa.4, ss.304-306, 2025 (Scopus)

7. Peripheral T-Cell Lymphoma Coexisting with Autoimmune Hemolytic Anemia: Analysis of Clinical Features

Candan O., Naghizada N., DEMİRTAŞ D., YANIK A. M., Salim S., Menguc M. U., et al.

Indian Journal of Hematology and Blood Transfusion , cilt.41, sa.1, ss.181-185, 2025 (SCI-Expanded)

8. Bortezomib-Based Salvage Followed by Autologous Transplantation in a Patient with HIV-Negative Plasmablastic Lymphoma

Candan O., Ulukoylu Menguc M., Demirtas D., Yanik A. M., YILMAZ A. F., ATAGÜNDÜZ I., et al.

Indian Journal of Hematology and Blood Transfusion , 2025 (SCI-Expanded)

9. The predictive value of HCT-CI and CCI comorbidity indices in predicting survival and mortality before allogeneic stem cell transplantation in acute leukemia patients: A single-centre experience

Candan O., Yenigun A., DEMİRTAŞ D., YANIK A. M., Ulukoylu Menguc M., UZUNOĞLU GÜREN C., et al.

Marmara Medical Journal , cilt.37, sa.3, ss.274-281, 2024 (ESCI)

10. The role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic leukemia

Candan O., Demirtas D., YANIK A. M., ATAGÜNDÜZ I., TOPTAŞ T.

Annals of Hematology , cilt.102, sa.12, ss.3647-3648, 2023 (SCI-Expanded)

11. Splenectomy in Immune Thrombocytopenia: A Retrospective Analysis of 25-Year Follow-up Data from a Tertiary Health Clinic

Ozkok S., ATAGÜNDÜZ I., Kara O., Sezgin A., Ozgumus T., Gecgel F., et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , cilt.38, sa.3, ss.516-521, 2022 (SCI-Expanded)

12. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic

SOY M., Atagunduz P., ATAGÜNDÜZ I., Sucak G. T.

RHEUMATOLOGY INTERNATIONAL , cilt.41, sa.1, ss.7-18, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

13. Quality of Life and Symptom Burden With First- and Second-generation Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myeloid Leukemia

BOSTAN H., TOPTAŞ T., Tanrikulu F. P., Kut K., Arikan F., Yilmaz F., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.20, sa.12, ss.836-842, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

14. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

SOY M., KESER G., Atagunduz P., Tabak F., ATAGÜNDÜZ I., KAYHAN S.

CLINICAL RHEUMATOLOGY , cilt.39, sa.7, ss.2085-2094, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

15. A case of conjunctival MALT lymphoma: successfully treated with solely extended rituximab therapy.

ÇELİKER ATABERK H., Toker E., ATAGÜNDÜZ I.

International ophthalmology , cilt.39, sa.3, ss.687-691, 2019 (SCI-Expanded)

16. Acquiered Aplastic Anemia Diagnosis and Therapy

ATAGÜNDÜZ I.

TÜRKİYE KLİNKLERİ , ss.30-37, 2018 (Hakemli Dergi)

17. Molecular screening and the clinical impacts of BCR-ABL KD mutations in patients with imatinib-resistant chronic myeloid leukemia

Kockan B., Toptaş T., Atagündüz I., Tuğlular A. T., Ozer A., Akkiprik M.

ONCOLOGY LETTERS , cilt.15, ss.2419-2424, 2018 (SCI-Expanded)

18. Horizontal melanonychia.

Salman A., Eser A., Atagunduz I. K., Ergun T.

Actas dermo-sifiliograficas , cilt.108, sa.5, ss.469-470, 2017 (Scopus)

19. Bullous Sweet's Syndrome: Report of an Atypical Case Presenting with Ring-Like, Figurate Lesions.

SALMAN A., Berenjian A., Eser A., Kaymakci F. D., Cinel L., ATAGÜNDÜZ I., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology , cilt.34, sa.1, ss.118-119, 2017 (SCI-Expanded)

20. Effects of Deeper Molecular Responses on Outcomes in Chronic Myeloid Leukemia Patients in Chronic Phase Treated With Imatinib Mesylate

ATAGÜNDÜZ I., TOPTAŞ T., Deniz R., Kara O., Eser A., Sezgin A., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , cilt.17, sa.2, ss.120-125, 2017 (SCI-Expanded)

21. Giant Intracranial Solitary Plasmacytoma

Kara O., TOPTAŞ T., ATAGÜNDÜZ I., BOZKURT S., ŞİRİKÇİ Ö., Tuglular T. F.

TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.4, ss.352-353, 2017 (SCI-Expanded)

22. Acute promyelocytic leukemia evolving from paroxysmal nocturnal hemoglobinuria: A rare occurrence

Eren R., TOPTAŞ T., ATAGÜNDÜZ I., Firatli Tuglular T.

MARMARA MEDICAL JOURNAL , cilt.29, sa.2, ss.114-116, 2016 (ESCI)

23. SUCCESSFUL TREATMENT OF SEVERE APLASTIC ANEMIA WITH ELTROMBOPAG A CASE REPORT

ESER A., TANRIKULU F. P., TOPTAŞ T., BOZKURT S., KOMBAK E., ATAGÜNDÜZ I., et al.

Medical Science and Discovery , cilt.3, 2016 (Hakemli Dergi)

24. Efficacy of N-acetylcysteine in preventing amphotericin B induced acute kidney injury

ERTÜRK ŞENGEL B., Tukenmez Tigen E., TOPTAŞ T., ATAGÜNDÜZ I., TUĞLULAR A. T., Ergonul M. O., et al.

MARMARA MEDICAL JOURNAL , cilt.29, sa.2, ss.73-78, 2016 (ESCI)

25. Pulmonary Endarterectomy in a Patient with Immune Thrombocytopenic Purpura

YILDIZELİ B., YANARTAŞ M., KESKİN S., ATAGÜNDÜZ I., ALTINAY E.

Case Reports in Vascular Medicine , cilt.2015, ss.1-3, 2015 (Hakemli Dergi)

26. Aplastic Anemia Associated with Oral Terbinafine: A Case Report and Review of the Literature

Kantarcioglu B., TÜRKÖZ H. K., Yilmaz G., Tanrikulu F. P., ATAGÜNDÜZ I., Adiguzel C., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.31, sa.4, ss.411-416, 2014 (SCI-Expanded)

27. REAL LIFE EXPERIENCE OF ANTI-FUNGAL PROPHYLAXIS WITH POSACONAZOLE IN PATIENTS WITH ACUTE LEUKEMIA AT A SINGLE CENTER LACKING HEPA-FILTER

Tuglular T., Tanrikulu F., Vergili A., Ozel A., Eser A., Adiguzel C., et al.

HAEMATOLOGICA , cilt.98, ss.726, 2013 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 41

1. NADIR BIR OLGU: ERITROLÖSEMI

KESKİN B., BOZKURT S., ATAGÜNDÜZ I.

Ulusal Patoloji Kongresi, Türkiye, 23 - 26 Ekim 2019, cilt.3, ss.150, (Tam Metin Bildiri)

2. QUALITY OF LIFE AND SYMPTOM BURDEN WITH FIRST AND SECOND GENERATION TYROSINE KINASE

TOPTAŞ T., BOSTAN H., KUT K., PEPEDİL TANRIKULU F., YILMAZ A. F., ATAGÜNDÜZ I., et al.

24. Congress of the European Hematology Association, 13 - 16 Haziran 2019, (Özet Bildiri)

3. KRONİK MYELOİD LÖSEMİ’DE İKİNCİ BASAMAK DASATİNİBVE NİLOTİNİB TEDAVİLERİNİN ETKİNLİK VE YAN ETKİKARŞILAŞTIRILMASI

ATAGÜNDÜZ I., GEÇGEL F., MEMİŞ T., TOPTAŞ T., YILMAZ A. F., İPEK Y., et al.

44. Ulusal Hematoloji Kongresi, Türkiye, 31 Ekim - 03 Kasım 2018, (Özet Bildiri)

4. THE FREQUENCY AND CLINICAL SIGNIFICANCE OF MEFV GENE MUTATIONS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA

Atagunduz I. K., Keklikkiran C., Toptas T., Kara O., Sezgin A., Gecgel F., et al.

22nd Congress of the European-Hematology-Association, Madrid, İspanya, 22 - 25 Haziran 2017, cilt.102, ss.590-591, (Özet Bildiri)

5. PRIMARY POSACONAZOLE PROPHYLAXIS IN ACUTE MYELOID LEUKEMIA - A SINGLE CENTER REAL LIFE EXPERIENCE

Tuglular T. F., Ozgumus T., Elibol T., Tanrikulu F. P., Gecgel F., Sezgin A., et al.

22nd Congress of the European-Hematology-Association, Madrid, İspanya, 22 - 25 Haziran 2017, cilt.102, ss.677-678, (Özet Bildiri)

6. IMMUNOHISTOCHEMICAL ANALYSIS OF CALRETICULIN MUTATIONS IN PRIMARY MYELOFIBROSIS (PRMF) PATIENTS: RESULTS OF OUR INSTITUTION IN THE JAK2V617F MUTATED AND JAK2V617F WILD TYPE PRMF PATIENTS

Bozkurt S. U., Gecgel F., Atagunduz I., Agyol Y., Turkoz K., Tuglular T.

22nd Congress of the European-Hematology-Association, Madrid, İspanya, 22 - 25 Haziran 2017, cilt.102, ss.806-807, (Özet Bildiri)

7. Immunohistochemical analysis of Calreticulin mutations in primary myelofibrosis (PRMF) patients: Results of our instution in the JAK2V617F mutated and JAK2V617F wild type PRMF patients

BOZKURT S., GEÇGEL F., ATAGÜNDÜZ I., AGYAOL Y., TURKÖZ K., TUĞLULAR A. T.

22nd European hematology Association Congress June 22-25-2017 Madrid Absract PB2027, Madrid, İspanya, 22 - 25 Haziran 2017, (Özet Bildiri)

8. Frequency And Clinical Significance Of MEFV Gene Mutations In Patients With Immune Thrombocytopenia

ATAGÜNDÜZ I., KEKLİKKIRAN Ç., TOPTAŞ T., KARA O., SEZGİN A., Geçgel F., et al.

22th Congress of the European Hematology Association, Madrid, İspanya, 22 - 25 Haziran 2017, (Özet Bildiri)

9. 18F-FDG PET/CT findings and baseline clinical parameters in multiple myeloma.

FIRATLI TUĞLULAR T., PEPEDİL TANRIKULU F., Toptas T., KARADENİZ A., ATAGÜNDÜZ I.

16th International Myeloma Workshop, 1 - 04 Mart 2017, cilt.17, ss.148-149, (Özet Bildiri)

10. Yalın Rituksimab tedavisi ile gerileyen konjonktival Malt Lenfoma olgusu

TOKER A. E., ÇELİKER H., GEÇGEL F., ATAGÜNDÜZ I.

TOD 50. ULUSAL KONGRESİ, Türkiye, 9 - 13 Kasım 2016, (Özet Bildiri)

11. The relation between initial 18F-FDG PET/CT findings and baseline clinical parameters in multiple myeloma

Tuglular T., Tanrikulu F. P., Toptas T., Karadeniz A., Eser A., Kara O., et al.

42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, İspanya, 3 - 06 Nisan 2016, cilt.51, (Özet Bildiri)

12. İmatinib tedavisinde direnç gösteren kronik miyeloid lösemi hastalarında BCR ABL geni kinaz bölgesi mutasyonlarının belirlenmesi ve klinik ilişkisi

KOÇKAN B., Topbaş T., ATAGÜNDÜZ I., TUĞLULAR A. T., ÖZER S. A., AKKİPRİK M.

II. Hematolojik Genetik Sempozyumu, Türkiye, 24 - 26 Şubat 2016, (Özet Bildiri)

13. İMATİNİB TEDAVİSİNE DİRENÇ GÖSTEREN KRONİK MİYELOİD LÖSEMİ HASTALARINDA BCR ABL GENİ KİNAZ BÖLGESİ MUTASYONLARININ BELİRLENMESİ VE KLİNİKLE İLİŞKİSİ

KOÇKAN B., TOPTAŞ T., ATAGÜNDÜZ I., TUĞLULAR A. T., ÖZER S. A., AKKİPRİK M.

2. Hematolojik Genetik Sempozyumu, İzmir, Türkiye, 24 - 26 Şubat 2016, (Özet Bildiri)

14. Ataksi Telenjiektazi Zemininde Gelişen T Hücreli Akut Lenfoblastik Lösemi

DİNÇER YAZAN C., SEZGİN A., BAŞGÖZE E., KARA O., ÖZGÜMÜŞ T., GEÇGEL F., et al.

41. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 21 - 24 Ekim 2015

15. AZASİTİDİN TEDAVİSİ İLE TAM REMİSYON SAĞLANAN YAŞLI AKUT MYELOBLASTİK LÖSEMİLİ HASTALARDA İDAME TEDAVİSİ HASTALIKSIZ SAĞ KALIMI UZATIR ÜÇ OLGU SUNUMU

ESER A., KARA O., TOPTAŞ T., SEZGİN A., ÖZGÜMÜŞ T., GEÇGEL F., et al.

41. Ulusal Hematoloji Kongresi, İstanbul, Türkiye, 21 - 24 Ekim 2015, ss.134

16. Hiperferritinemi ve Demir Eksikliği Anemisi Birlikteliği

ŞENTÜRK N., SEZGİN A., ÖZGÜMÜŞ T., KARA O., GEÇGEL F., ESER A., et al.

41. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 21 - 24 Ekim 2015

17. Azasitidin Tedavisi ile Tam Remisyon Sağlanan Yaşlı Akut Myeloblastik Lösemili Hastalarda İdame Tedavisi Hastalıksız Sağ Kalımı Uzatır Üç Olgu Sunumu

ESER A., KARA O., TOPTAŞ T., SEZGİN A., ÖZGÜMÜŞ T., GEÇGEL F., et al.

41. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 21 - 24 Ekim 2015

18. Kemik İliği Metastazı Olmayan Karsinom Olgusunda Sekonder Miyelofibroz

KEKLİKKIRAN Ç., SEZGİN A., BAŞGÖZE E., KARA O., ÖZGÜMÜŞ T., GEÇGEL F., et al.

41. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 21 - 24 Ekim 2015

19. Romatoid Artrit Olgusunda Hemofagositik Lenfohistiyositoz

DEMİRCAN N. C., SEZGİN A., KÖMÜRCÜ B., AKÇAY S., ÖZGÜMÜŞ T., KARA O., et al.

41. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 21 - 24 Ekim 2015

20. Generalized acquired cutis laxa with granuloma formation histologically as a presenting feature of monoclonal gammopathy of undetermined significance

SEÇKİN GENÇOSMANOĞLU D., ATAGÜNDÜZ I., SARIÇAM M. H., DEMİRKESEN C., SALMAN A., KARA O., et al.

23rd World Congress of Dermatology, 8 - 13 Haziran 2015

21. Nadir Görülen Multiple Myelom Alt Tipleri IgGM IgGD IgE Myelom

ATAGÜNDÜZ I.

6. Ulusal Lenfoma Myeloma Kongresi, Antalya, Türkiye, 9 - 12 Nisan 2015

22. AZACYTIDINE IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

Tuglular T. F., Tanrikulu F. P., Atagunduz I. K., Kara O., Sezgin A., Ozgumus T., et al.

13th International Symposium on Myelodysplastic Syndromes (MDS), Washington, Kiribati, 29 Nisan - 02 Mayıs 2015, cilt.39, (Özet Bildiri)